ZetrOz | Top Ultrasound Solution Company 2019

MedTech Outlook Magazine

ZetrOz
Wearable Therapeutic Ultrasound

George K. Lewis, President & CEO, ZetrOzGeorge K. Lewis, President & CEO
There are several recorded cases of soft tissue injury (STI) suffered by active duty U.S. Army personnel. These kinds of low-extremity wounds—although not fatal—results in decreased physical activity and substantial medical costs. Especially, for active duty soldiers, STI delays their return to duty, and the prolonged recovery time often causes acute depression among the patriots. For the past few decades, therapeutic ultrasound has been used to help such soldiers repress the STI pain and heal faster. Despite its widespread use, the ultrasound machines are confined within the boundaries of health care centers. The lack of mobility of the therapy coupled with its limited dosage time more often than not causes delayed treatment, and hence puts a hefty financial and psychological burden on the patients. However, thanks to ZetrOz, a medical device manufacturing company from Connecticut, soldiers can now recover from soft-tissue injury 50 percent faster with the company’s proprietary wearable therapeutic ultrasound device, thus eliminating the need for regular visits to hospitals or clinics.

Founded in 2009, ZetrOz started its journey as a key manufacturer of wearable low-intensity ultrasound system, UltrOz, for the equestrian market to deliver sustained acoustic medicine (sam). Soon, with FDA approval ZetrOz released sam Sport—wearable ultrasound systems for athletes with STI and musculoskeletal pain. Following the success in the sporting arena, today, ZetrOZ Systems has developed sam Pro 2.0 for commercial use to treat arthritis and other degenerative conditions. At present, Sam is the only FDA-cleared, wearable low-intensity ultrasound device in the market.

Considering sam’s effectiveness in treating non-invasive soft tissue injuries, the U.S. Department of Veterans Affairs (VA) and the Department of Defense (DoD) have also approved sam to treat their armed forces.

Instead of consuming opiates or going for surgery, civilians, veterans, and active duty soldiers can use ZetrOz’s wearable therapeutic ultrasound—sam—for pain management and physical therapy


With the Government approval of wearable therapeutic ultrasound for its current and retired armed forces, ZetrOz marked its inception in the U.S. government space. “sam is now a part of VA and DoD’s standard healing procedure for STI. Instead of consuming opiates or going for surgery, civilians, veterans, and active duty soldiers can use ZetrOz’s wearable therapeutic ultrasound— sam—for pain management and physical therapy,” says Dwayne Hofstatter, chief innovation officer at ZetrOz.

ZetrOz’s family of sam products is capable of providing ultrasound therapy to a patient for up to three-four hours daily. Powered by a rechargeable battery, sam uses a miniaturized ultrasound device to deliver the low intensity-long duration mode of treatment, using 18 times more energy than clinical ultrasound therapy. Before releasing the product in the market, sam went through different levels of clinical verification and validation trials to ensure the product can be easily and successfully applied. The sam clinical study conducted across trial patients in the U.S. demonstrated a striking reduction in pain related to osteoarthritis and chronic tendinopathy. “At the same time, sam has also demonstrated its capability to improve the life quality of its patients,” boasts Hofstatter.

ZetrOZ Systems is now heavily investing in research and development to expand the capabilities of sam to find its usage in different patient demographics. To do so, ZetrOZ has entered into collaborative partnerships with more than 20 VA hospitals and clinics around the U.S. to make sam available to more civilians and government personnel. ZetrOz is also collaborating with U.S. DoD to extend the possibility of using sam to heal open wounds caused by burns and shrapnel, and speed-up post-surgery healing of the soldiers to prevent infection. Above all, ZetrOZ is joining forces with federal institutes and universities across the U.S. to develop new sam-based medical products and usher a new dimension in soft-tissue injury treatment.

Top 10 Ultrasound Solution Companies - 2019

Company
ZetrOz

Management
George K. Lewis, President & CEO

Description
ZetrOZ Systems develops wearable bioelectronic devices for the delivery of Sustained Acoustic Medicine. Built on their proprietary miniaturized ultrasound platform designed for the treatment of acute and chronic musculoskeletal conditions, sam devices are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain. sam Sport delivers sustained acoustic medicine for the treatment of select medical conditions such as the relief of pain, the relief of muscle spasm, the treatment of joint contracture and the local increase in circulation while sam Pro offers the same benefit to commercial patients

ZetrOz News

ZetrOZ Systems Showcased the sam X1 Wireless Wearable Device at CATS Symposium for Athletic Trainers

Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.
TRUMBULL - ZetrOZ Systems presented the benefits of its sam X1 wireless wearable device at the College Athletic Trainers' Society (CATS) symposium May 18-20, 2023, at The Orleans Hotel and Casino in Las Vegas. As displayed to sports physicians and trainers in attendance, sam X1 can accelerate soft-tissue repair and deliver sustained acoustic medicine that has been approved for a convenient home-use prescription.
The Society was founded to provide and manage healthcare for the intercollegiate student-athlete through athletic trainers and healthcare professionals. At the symposium, ZetrOZ focused on how sam ultrasound treatment can help athletes return to form faster and how patients have reported significant pain reduction in the past.
ZetrOZ demonstrated how the sam unit, a long-duration low-intensity soft-tissue repair ultrasound device, can help patients supercharge their injury healing process, providing healthcare professionals with a proven method of accelerating and enhancing soft tissue healing.
"Attending CATS each year is a great opportunity to share the latest medical innovations with the leading front-line healthcare providers in sports medicine," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "This year we had the opportunity to share the sam® X1 wireless device, which is advancing the sam® platform and accelerating return to play for common overuse injuries. We are proud to be partners with the CATS organization."
The sam® X1 and 2.0 units soft tissue treatment devices are the only FDA-cleared, drug-free, and non-invasive wearable ultrasound units of their kind approved for daily home use.
Sustained acoustic medicine is a daily ultrasound treatment that can reduce the need for pain medication and surgery. Using mechanobiological technology, sam® increases blood vessel diameters to improve blood flow, increasing oxygenated hemoglobin at the site, and removing cytokine enzymes and cellular waste for rapid healing and reduced pain.
With support from the National Science Foundation, the National Institutes of Health, and other reputed health organizations, ZetrOZ has researched and developed sustained acoustic medicine technology into a powerful, non-invasive alternative to invasive surgery and potentially addictive pain medication. It has been clinically proven by over 30 studies to reduce joint pain, treat pain and improve function.